Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
AssigneeBrudy Technology S.L.
InventorsJoan Carles DOMINGO PEDROL, Jose Antonio VILLEGAS GARCIA
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with oxidative damage to DNA and with physical exercise.
Claims22
1-47. (canceled)
A method comprising administering a foodstuff comprising docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or DHA-derived EPA to a subject affected by cellular oxidative damage, wherein said DHA, EPA, or DHA-derived EPA is incorporated into a glyceride, and
- wherein said DHA, EPA, or DHA-derived EPA is in a percentage by weight between 40 and 100% in relation to the total fatty acids or said DHA, EPA or DHA-derived EPA is incorporated into a sn-2 position of the glyceride.
A method for treating cellular oxidative damage in a subject comprising administering an effective amount of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or DHA-derived EPA to said subject, wherein said DHA, EPA, or DHA-derived EPA, is incorporated into a glyceride, and
- wherein said DHA, EPA, or DHA-derived EPA is in a percentage by weight between 40 and 100% in relation to the total fatty acids or said DHA, EPA or DHA-derived EPA is incorporated into a sn-2 position of the glyceride.
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or DHA-derived EPA, wherein said DHA, EPA, or DHA-derived EPA is incorporated into a glyceride, and wherein said DHA, EPA, or DHA-derived EPA is in a percentage by weight between 40 and 100% in relation to the total fatty acids or said DHA, EPA or DHA-derived EPA is incorporated into a sn-2 position of the glyceride
Dependencies are inferred from the claim text.